LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.66 | 770.25 | 1041 | 1090 | 0.9551 | 0.8245 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.66 | 770.25 | 1192 | 1090 | 1.0936 | 1.3910 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.06 | 770.25 | 1154 | 1218 | 0.9471 | 0.8422 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.06 | 770.25 | 1341 | 1218 | 1.1005 | 1.3115 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.28 | 770.25 | 1260 | 1358 | 0.9278 | 0.8248 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.28 | 770.25 | 1468 | 1358 | 1.0809 | 1.1995 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.50 | 770.25 | 1379 | 1497 | 0.9210 | 0.8356 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.50 | 770.25 | 1612 | 1497 | 1.0766 | 1.1601 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.73 | 770.25 | 1474 | 1664 | 0.8856 | 0.7929 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.73 | 770.25 | 1759 | 1664 | 1.0568 | 1.1019 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.95 | 770.25 | 1596 | 1832 | 0.8709 | 0.7908 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.95 | 770.25 | 1882 | 1832 | 1.0270 | 1.0431 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 21.17 | 770.25 | 1766 | 2008 | 0.8793 | 0.8224 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 21.17 | 770.25 | 2058 | 2008 | 1.0247 | 1.0356 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.39 | 770.25 | 1930 | 2244 | 0.8599 | 0.8136 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.39 | 770.25 | 2284 | 2244 | 1.0176 | 1.0227 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.62 | 770.25 | 2085 | 2514 | 0.8291 | 0.7920 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.62 | 770.25 | 2493 | 2514 | 0.9913 | 0.9898 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.84 | 770.25 | 2329 | 2833 | 0.8218 | 0.8017 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.84 | 770.25 | 2766 | 2833 | 0.9761 | 0.9744 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 30.06 | 770.25 | 2486 | 3106 | 0.8004 | 0.7904 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 30.06 | 770.25 | 3046 | 3106 | 0.9806 | 0.9807 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 32.28 | 770.25 | 2714 | 3392 | 0.7999 | 0.8018 | MN20160304_L02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 32.28 | 770.25 | 3263 | 3392 | 0.9617 | 0.9638 | MN20160304_L02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 34.50 | 770.25 | 2943 | 3712 | 0.7928 | 0.8055 | MN20160304_L02 | E17 |